Comparison between Pediatric Crohn’s Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: We aimed to compare the differences in pediatric Crohn’s disease (CD) and ulcerative colitis (UC) at diagnosis in Korea. Methods: This was a multicenter, registry-based, inception cohort study conducted at five centers in Korea between 2013 and 2017. Baseline demographics, clinical characteristics, and results from laboratory, endoscopic, radiologic examinations were compared between pediatric CD and UC patients who were <19 years old at diagnosis. Results: A total 307 patients were included (227 CD [73.9%] and 80 UC [26.1%]). The male to female ratio was 2.49:1 for CD, and 1.49:1 for UC (p=0.019). Median age at diagnosis was 14.4 years (interquartile range, 12.4 to 16.2) for CD, and 14.4 years (interquartile range, 11.7 to 16.5) for UC (p=0.962). Hematochezia was the only dominant symptom in UC patients compared to CD patients (86.2% vs 30.8%, p<0.001). White blood cell counts, platelet counts, erythrocyte sedimentation rate, and C-reactive protein levels were significantly higher, and serum albumin level was significantly lower in CD patients than in UC patient. Anti-Saccharomyces cerevisiae antibody was positive in 44.5% and 16.2% of CD and UC patients, respectively (p<0.001), and antineutrophil cytoplasmic antibody was positive in 15.0% and 58.8% of CD and UC patients, respectively (p<0.001). Terminal ileal involvement was prominent in CD, while rectal involvement was more prominent in UC. Small bowel involvement and perianal perforating diseases were also more prominent in CD. Conclusions: This is the first a multicenter study in Korea to compare the differences between pediatric CD and UC at diagnosis in Korea. A large-scale, national study is expected to better clarify these findings in the future.
Abstract
Background/Aims: We aimed to compare the differences in pediatric Crohn’s disease (CD) and ulcerative colitis (UC) at diagnosis in Korea. Methods: This was a multicenter, registry-based, inception cohort study conducted at five centers in Korea between 2013 and 2017. Baseline demographics, clinical characteristics, and results from laboratory, endoscopic, radiologic examinations were compared between pediatric CD and UC patients who were <19 years old at diagnosis. Results: A total 307 patients were included (227 CD [73.9%] and 80 UC [26.1%]). The male to female ratio was 2.49:1 for CD, and 1.49:1 for UC (p=0.019). Median age at diagnosis was 14.4 years (interquartile range, 12.4 to 16.2) for CD, and 14.4 years (interquartile range, 11.7 to 16.5) for UC (p=0.962). Hematochezia was the only dominant symptom in UC patients compared to CD patients (86.2% vs 30.8%, p<0.001). White blood cell counts, platelet counts, erythrocyte sedimentation rate, and C-reactive protein levels were significantly higher, and serum albumin level was significantly lower in CD patients than in UC patient. Anti-Saccharomyces cerevisiae antibody was positive in 44.5% and 16.2% of CD and UC patients, respectively (p<0.001), and antineutrophil cytoplasmic antibody was positive in 15.0% and 58.8% of CD and UC patients, respectively (p<0.001). Terminal ileal involvement was prominent in CD, while rectal involvement was more prominent in UC. Small bowel involvement and perianal perforating diseases were also more prominent in CD. Conclusions: This is the first a multicenter study in Korea to compare the differences between pediatric CD and UC at diagnosis in Korea. A large-scale, national study is expected to better clarify these findings in the future.
참고문헌 (34)
- Baumgart DC, "Inflammatory bowel disease : clinical aspects and established and evolving therapies", Lancet, 369, pp.1641~1657 (2007)
- Zhang YZ, "Inflammatory bowel disease : pathogenesis", World J Gastroenterol, 20, pp.91~99 (2014)
- Emiko Mizoguchi, "Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models", Intestinal research, 18(2), pp.151~167 (2020), 대한장연구학회[DOI]
- Ng SC, "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century : a systematic review of population-based studies", Lancet, 390, pp.2769~2778 (2017)
- 송은미, "Natural history of inflammatory bowel disease: a comparison between the East and the West", Intestinal research, 20(4), pp.418~430 (2022), 대한장연구학회[DOI]
- GBD 2017 Inflammatory Bowel Disease Collaborators, "The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017 : a systematic analysis for the Global Burden of Disease Study 2017", Lancet Gastroenterol Hepatol, 5, pp.17~30 (2020)
- Park SH, "A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong district of Seoul, Korea in 1986-2015", J Crohns Colitis, 13, pp.1410~1417 (2019)
- Sowon Park, "Increasing incidence of inflammatory bowel disease in children and adolescents: significance of environmental factors", Clinical and Experimental Pediatrics, 63(9), pp.337~344 (2020), 대한소아청소년과학회[DOI]
- Griffiths AM, "Specificities of inflammatory bowel disease in childhood", Best Pract Res Clin Gastroenterol, 18, pp.509~523 (2004)
- Rosen MJ, "Inflammatory bowel disease in children and adolescents", JAMA Pediatr, 169, pp.1053~1060 (2015)
- Sýkora J, "Current global trends in the incidence of pediatric-onset inflammatory bowel disease", World J Gastroenterol, 24, pp.2741~2763 (2018)
- Kwak MS, "Emerging trends of inflammatory bowel disease in South Korea : a nationwide population-based study", J Gastroenterol Hepatol, 34, pp.1018~1026 (2019)
- 홍석진, "Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study", Journal of Korean Medical Science, 33(18), pp.1~8 (2018), 대한의학회
- Hyeon Ah Lee, "Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data", Gut and Liver, 9(6), pp.756~760 (2015), 거트앤리버 소화기연관학회협의회
- Levine A, "ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents", J Pediatr Gastroenterol Nutr, 58, pp.795~806 (2014)
- 김재현, "The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects", Clinical and Experimental Pediatrics, 61(5), pp.135~149 (2018), 대한소아청소년과학회
- Levine A, "Pediatric modification of the Montreal classification for inflammatory bowel disease : the Paris classification", Inflamm Bowel Dis, 17, pp.1314~1321 (2011)
- Hyams JS, "Development and validation of a pediatric Crohn’s disease activity index", J Pediatr Gastroenterol Nutr, 12, pp.439~447 (1991)
- Turner D, "Appraisal of the pediatric ulcerative colitis activity index(PUCAI)", Inflamm Bowel Dis, 15, pp.1218~1223 (2009)
- Kim BJ, "Characteristics and trends in the incidence of inflammatory bowel disease in Korean children : a single-center experience", Dig Dis Sci, 55, pp.1989~1995 (2010)
- Kim HJ, "Clinical characteristics and long-term outcomes of paediatric Crohn’s disease : a singlecentre experience", J Crohns Colitis, 11, pp.157~164 (2017)
- Ben Kang, "Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts", Pediatric Gastroenterology, Hepatology & Nutrition, 23(1), pp.49~62 (2020), 대한소아소화기영양학회[DOI]
- de Bie CI, "Disease phenotype at diagnosis in pediatric Crohn’s disease : 5-year analyses of the EUROKIDS Registry", Inflamm Bowel Dis, 19, pp.378~385 (2013)
- Levine A, "Atypical disease phenotypes in pediatric ulcerative colitis : 5-year analyses of the EUROKIDS Registry", Inflamm Bowel Dis, 19, pp.370~377 (2013)
- Poddar U, "Pediatric inflammatory bowel disease : is it really uncommon in Asian children", JGH Open, 4, pp.860~866 (2020)
- Katsuhiro Arai, "Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry", Intestinal research, 18(4), pp.412~420 (2020), 대한장연구학회[DOI]
- Shah SC, "Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region", Aliment Pharmacol Ther, 49, pp.904~911 (2019)
- Kugathasan S, "Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin : a statewide population-based study", J Pediatr, 143, pp.525~531 (2003)
- Palder SB, "Perianal complications of pediatric Crohn's disease", J Pediatr Surg, 26, pp.513~515 (1991)
- Kang B, "Mucosal healing in paediatric patients with moderate-to-severe luminal Crohn’s disease under combined immunosuppression : escalation versus early treatment", J Crohns Colitis, 10, pp.1279~1286 (2016)
- Chen P, "Serum biomarkers for inflammatory bowel disease", Front Med(Lausanne), 7, pp.123~ (2020)
- Fagan EA, "Serum levels of Creactive protein in Crohn’s disease and ulcerative colitis", Eur J Clin Invest, 12, pp.351~359 (1982)
- Alper A, "Correlation of erythrocyte sedimentation rate and C-reactive protein with pediatric inflammatory bowel disease activity", J Pediatr Gastroenterol Nutr, 65, pp.e25~e27 (2017)
- Birimberg-Schwartz L, "pANCA and ASCA in children with IBD-unclassified, Crohn’s colitis, and ulcerative colitis : a longitudinal report from the IBD Porto Group of ESPGHAN", Inflamm Bowel Dis, 22, pp.1908~1914 (2016)